ImmunoPrecise Antibodies basic eps from 2022 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
ImmunoPrecise Antibodies basic eps from 2022 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.